MWPCG
CDMO

Measured Wealth Private Client Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Measured Wealth Private Client Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-600
Closed -$4K – 740
2018
Q3 		$4K Buy
+600
New +$3.56K ﹤0.01% 730

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Measured Wealth Private Client Group's CDMO Position: Q4 2018 in Review

Measured Wealth Private Client Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2018, closing a stake of 600 shares — an estimated $4K sold.

Measured Wealth Private Client Group first reported a position in CDMO in Q3 2018 and held it in 1 quarter. The position peaked at $4K in Q3 2018. 101 funds tracked by Wall St. Rank hold CDMO as of Q4 2018.

  • Measured Wealth Private Client Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Measured Wealth Private Client Group sold 600 Avid Bioservices, Inc. Common Stock shares in Q4 2018, an estimated $4K.
  • Measured Wealth Private Client Group first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Measured Wealth Private Client Group's Avid Bioservices, Inc. Common Stock position peaked at $4K in Q3 2018.
  • 101 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2018.

Based on Measured Wealth Private Client Group's 13F filing for Q4 2018, filed 7 Feb 2019.